An intermediate compound II of epirubicin hydrochloride
Patent Information
- Application Number
- CN201910928241.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2019-09-28
- Publication Date
- 2026-08-28
- Estimated Expiration
- 2039-09-28
AI Technical Summary
[0013]综上所述,在已经被报道的制备表柔比星的技术方法中,主要存在以下问题:收率低、易产生较大杂质、操作繁琐、生产成本高、技术要求高,不适合工业化生产,因此,研究并且提供一种新的表柔比星的合成方法具有十分重要的意义
[0048]本发明提供了一种新的盐酸表柔比星中间体化合物II,该化合物合成简便易控;利用该化合物制备表柔比星,路线操作简便,提高了操作的安全性;节约了生产成本,更适于工业化生产。该方法所制得的目标产品具有较高的纯度、收率,能克服现有技术操作繁琐、生产成本高、技术要求高等缺陷。
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Claims
1. An intermediate compound of epirubicin hydrochloride, as shown in Formula II, with the following structural formula:
2. A method for preparing compound II as described in claim 1, characterized in that, The reaction of compound I with diacetic acid iodotoluene yields epirubicin intermediate compound II, as shown in the following reaction formula:
3. The method for preparing epirubicin hydrochloride intermediate compound II according to claim 2, characterized in that, Specifically, the following steps are included: Compound I was dissolved in organic solvent A, and diacetic acid iodobenzene was added. The reaction was carried out under controlled temperature. After the reaction was completed, the mixture was extracted with an extractant, the organic layer was collected, concentrated, and crystallization solvent 1 was added to induce crystallization. The mixture was then filtered and dried to obtain intermediate compound II.
4. The preparation method according to claim 3, characterized in that, The organic solvent A is one or a combination of methanol, ethanol, isopropanol, benzene, toluene, tetrahydrofuran, and N,N-dimethylformamide.
5. The preparation method according to claim 3, characterized in that, The molar ratio of compound I to diacetic acid iodobenzene is 1:1.0 to 1.
3.
6. The preparation method according to claim 3, characterized in that, The reaction temperature is 0–10°C.
7. The preparation method according to claim 3, characterized in that, The extractant is one of ethyl acetate / purified water, dichloromethane / purified water, or chloroform / purified water.
8. The preparation method according to claim 3, characterized in that, The crystallization solvent 1 is one of acetone, n-hexane, pentane, acetonitrile, and chloroform.
9. Use of the intermediate compound II of claim 1 in the preparation of epirubicin.
10. The use as described in claim 9, characterized in that, Its synthetic route is as follows: The specific method is as follows: Step 1. Add compound II to organic solvent B, stir to dissolve, add reducing agent, react under controlled temperature, after the reaction is complete, add extractant to extract, dry the organic phase with anhydrous sodium sulfate, filter, concentrate under reduced pressure, and dry to obtain compound III; Step 2. Dissolve intermediate compound III in organic solvent C, add 0.1M sodium hydroxide solution dropwise, react under controlled temperature, extract the organic phase, adjust pH, concentrate, add crystallization solvent 2 to crystallize, filter to obtain the target product epirubicin hydrochloride IV.
Citation Information
Patent Citations
Preparation method of epirubicin and its intermediates
CN105229019B
Gene engineering bacteria capable of producing epirubicin, and applications thereof
CN107541481A
Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process
US4345068A
Process for preparing epirubicin or acid addition salts thereof from daunorubicin
US5874550A
Process for the preparation of anthracycline antibiotics
US5945518A